Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Hims & Hers Health, Inc. (HIMS:NYSE), powered by AI.
Hims & Hers Health, Inc. is currently trading at $27.41. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Hims & Hers Health, Inc. on Alpha Lenz.
Hims & Hers Health, Inc.'s P/E ratio is 47.0.
“Hims & Hers Health, Inc. trades at a P/E of 47.0 (premium valuation) with strong ROE of 30.7%. 3Y revenue CAGR of 75.8% highlights clear growth momentum.”
Ask for details →Hims & Hers Health, Inc. is a telehealth service provider that aims to simplify and enhance healthcare access for consumers. The company specializes in personal care and wellness products and services, offering both prescription and over-the-counter solutions. With a focus on destigmatizing health and wellness issues, Hims & Hers addresses areas such as dermatology, sexual health, hair care, and mental wellness, appealing to a broad demographic looking for convenient and private healthcare options. By facilitating online consultations with licensed medical professionals, the company allows users to receive medical advice, treatments, and prescriptions, all accessible from the comfort of their homes. Hims & Hers plays a significant role in the growing digital healthcare market, leveraging technology to provide more accessible and personalized healthcare experiences. Headquartered in San Francisco, the company capitalizes on the increase in demand for telehealth services, buoyed by advancements in digital health trends and the expanding e-commerce space for healthcare solutions.
“Hims & Hers Health, Inc. trades at a P/E of 47.0 (premium valuation) with strong ROE of 30.7%. 3Y revenue CAGR of 75.8% highlights clear growth momentum.”
Ask for details →Hims & Hers Health, Inc. (ticker: HIMS) is a company listed on NYSE in the Consumer Defensive sector (Household & Personal Products). It has approximately 1,637 employees. Market cap is $5.9B.
The current price is $27.41 with a P/E ratio of 46.96x and P/B of 12.42x.
ROE is 30.71% and operating margin is 4.19%. Annual revenue is $1.5B.